Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Statistics

Total Valuation

TPEX:6499 has a market cap or net worth of TWD 8.50 billion. The enterprise value is 7.77 billion.

Market Cap	8.50B
Enterprise Value	7.77B

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6499 has 92.14 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	92.14M
Shares Outstanding	92.14M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.34%
Owned by Insiders (%)	12.34%
Owned by Institutions (%)	2.62%
Float	49.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.27
PB Ratio	6.80
P/TBV Ratio	8.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.50
EV / Sales	20.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.48

Financial Position

The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.10.

Current Ratio	5.98
Quick Ratio	5.68
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-192.10

Financial Efficiency

Return on equity (ROE) is -52.65% and return on invested capital (ROIC) is -30.02%.

Return on Equity (ROE)	-52.65%
Return on Assets (ROA)	-27.54%
Return on Invested Capital (ROIC)	-30.02%
Return on Capital Employed (ROCE)	-59.05%
Revenue Per Employee	9.79M
Profits Per Employee	-18.97M
Employee Count	39
Asset Turnover	0.21
Inventory Turnover	12.21

Taxes

Income Tax	-416,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +108.56% in the last 52 weeks. The beta is 0.76, so TPEX:6499's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+108.56%
50-Day Moving Average	101.96
200-Day Moving Average	86.99
Relative Strength Index (RSI)	37.52
Average Volume (20 Days)	930,482

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6499 had revenue of TWD 381.90 million and -739.79 million in losses. Loss per share was -8.02.

Revenue	381.90M
Gross Profit	51.14M
Operating Income	-794.34M
Pretax Income	-790.96M
Net Income	-739.79M
EBITDA	-738.77M
EBIT	-794.34M
Loss Per Share	-8.02

Balance Sheet

The company has 937.37 million in cash and 125.06 million in debt, giving a net cash position of 812.31 million or 8.82 per share.

Cash & Cash Equivalents	937.37M
Total Debt	125.06M
Net Cash	812.31M
Net Cash Per Share	8.82
Equity (Book Value)	1.25B
Book Value Per Share	12.75
Working Capital	867.06M

Cash Flow

In the last 12 months, operating cash flow was -646.34 million and capital expenditures -30.28 million, giving a free cash flow of -676.62 million.

Operating Cash Flow	-646.34M
Capital Expenditures	-30.28M
Free Cash Flow	-676.62M
FCF Per Share	-7.34

Margins

Gross margin is 13.39%, with operating and profit margins of -208.00% and -193.71%.

Gross Margin	13.39%
Operating Margin	-208.00%
Pretax Margin	-207.11%
Profit Margin	-193.71%
EBITDA Margin	-193.44%
EBIT Margin	-208.00%
FCF Margin	n/a

Dividends & Yields

TPEX:6499 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	-8.70%
FCF Yield	-7.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 23, 2023. It was a forward split with a ratio of 1.049992864.

Last Split Date	Aug 23, 2023
Split Type	Forward
Split Ratio	1.049992864

Scores

TPEX:6499 has an Altman Z-Score of 12.5 and a Piotroski F-Score of 2.

Altman Z-Score	12.5
Piotroski F-Score	2